Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-244324
Filing Date
2024-10-25
Accepted
2024-10-25 18:16:55
Documents
1
Group Members
STAN V. SMITH TRUST DATED 1993

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d902674dsc13da.htm SC 13D/A 50257
  Complete submission text file 0001193125-24-244324.txt   51619
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Subject) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-93731 | Film No.: 241398096
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address
Smith Stan (Filed by) CIK: 0001913199 (see all company filings)

Type: SC 13D/A